MARKSANS quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Marksans Pharma Ltd reported sales of ₹940 Cr, operating profit of ₹214 Cr (OPM 23%) and net profit of ₹144 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.
MARKSANS quarterly results (₹ Cr)
Metric
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
682
708
620
720
754
856
841
940
YoY Sales growth
16
27
5
12
11
21
36
30
Expenses
543
582
520
576
594
661
628
726
Operating Profit
139
127
100
144
161
195
213
214
OPM
20%
18%
16%
20%
21%
23%
25%
23%
Other Income
28
15
6
22
20
35
25
18
Interest
3
3
6
6
6
6
7
7
Depreciation
21
23
23
27
24
24
25
32
Profit before tax
143
116
77
133
151
200
207
194
Tax
27%
22%
24%
26%
25%
25%
23%
26%
Net Profit
105
91
58
99
114
149
159
144
EPS in Rs
2.31
2
1.29
2.17
2.5
3.27
3.47
3.12
MARKSANS profit & loss, annual (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
TTM
Sales
1,491
1,852
2,177
2,623
2,951
3,392
Sales growth
8
24
18
20
13
24
Expenses
1,232
1,513
1,719
2,090
2,350
2,608
Operating Profit
259
340
459
533
601
784
OPM
17%
18%
21%
20%
20%
23%
Other Income
42
59
50
66
82
99
Interest
8
9
11
12
24
26
Depreciation
45
52
74
83
99
106
Profit before tax
248
338
424
504
561
751
Tax
25%
21%
26%
24%
25%
-
Net Profit
187
265
315
383
420
566
EPS in Rs
4.51
5.88
6.92
8.4
9.22
12.36
Dividend Payout
6%
9%
9%
10%
10%
-
MARKSANS balance sheet (₹ Cr)
Metric
Mar 2024
Mar 2025
Sep 2025
Mar 2026
Sep 2026
Equity Capital
45
45
45
45
45
Reserves
2,020
2,422
2,643
2,978
3,287
Borrowings
244
322
332
343
465
Other Liabilities
372
451
422
489
563
Total Liabilities
2,681
3,240
3,442
3,856
4,360
Fixed Assets
776
982
1,054
1,044
1,313
CWIP
9
27
7
59
5
Investments
27
1
1
0
62
Other Assets
1,869
2,230
2,381
2,753
2,979
Total Assets
2,681
3,240
3,442
3,856
4,360
MARKSANS cash flows (₹ Cr)
Metric
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Cash from Operating Activity
99
237
230
207
458
Cash from Investing Activity
-84
-259
-141
-49
-249
Cash from Financing Activity
80
198
-69
-65
-71
Net Cash Flow
94
176
21
93
138
Free Cash Flow
53
184
22
35
329
CFO/OP
66%
88%
77%
62%
99%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit